These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 46657)

  • 61. T-cell subsets in lesions of systemic and discoid lupus erythematosus.
    Kohchiyama A; Oka D; Ueki H
    J Cutan Pathol; 1985 Dec; 12(6):493-9. PubMed ID: 3878372
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Successful treatment of generalized discoid lupus erythematosus with imiquimod cream 5%: a case report and review of the literature.
    Turan E; Sinem Bagci I; Turgut Erdemir A; Salih Gurel M
    Acta Dermatovenerol Croat; 2014; 22(2):150-9. PubMed ID: 25102804
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hardness and Painful Lesion of the Breast.
    Vilas-Sueiro A; González-Vilas D; Aguilera C; Monteagudo B; De Las Heras C
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):305-306. PubMed ID: 30064607
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cutaneous lupus erythematosus. Recognition of its many forms.
    Clark SK
    Postgrad Med; 1986 Apr; 79(5):195-203. PubMed ID: 3960799
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative analysis of the quality of life of patients with discoid lupus erythematosus and systemic lupus erythematosus with skin injuries.
    Martins PR; Skare T; Ferrari TA; Silva AP; Alessio BF
    An Bras Dermatol; 2012; 87(2):326-8. PubMed ID: 22570048
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum levels of the regulatory cytokines transforming growth factor-β and interleukin-10 are reduced in patients with discoid lupus erythematosus.
    Antiga E; Del Bianco E; Difonzo E; Fabbri P; Caproni M
    Lupus; 2011 May; 20(6):556-60. PubMed ID: 21372199
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clq binding activity in lupus erythematosus: correlation with the "lupus band test".
    Tappeiner G; O'Loughlin S; Jordon RE
    J Invest Dermatol; 1978 Apr; 70(4):187-90. PubMed ID: 305943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discoid lupus erythematosus following herpes zoster.
    Anyanwu CO; Sommer LL; Kuzyshyn H; Camacho JM; Eid HM; Heymann WR
    Cutis; 2018 May; 101(5):370-372. PubMed ID: 29894527
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Direct immunofluorescence in lupus erythematosus (LE).
    Isfer RS; Sanches Júnior JA; Festa Neto C; Cernea SS; de Oliveira ZN; Vilela MA; Silva ML; Miyachi LM; Fukumori LM; da Silva SR
    Sao Paulo Med J; 1996; 114(2):1141-7. PubMed ID: 9077025
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanisms of tissue injury in systemic lupus erythematosus.
    Koffler D
    Pathobiol Annu; 1975; 5():221-47. PubMed ID: 1105320
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cutaneous lupus erythematosus--a study of clinical and laboratory prognostic factors in 65 patients.
    Healy E; Kieran E; Rogers S
    Ir J Med Sci; 1995; 164(2):113-5. PubMed ID: 7607834
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epitope mapping of histone 5 (H5) with systemic lupus erythematosus, procainamide-induced lupus and hydralazine-induced lupus sera.
    Pauls JD; Edworthy SM; Fritzler MJ
    Mol Immunol; 1993 Jun; 30(8):709-19. PubMed ID: 7684819
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus?
    Merola JF; Chang CA; Sanchez MR; Prystowsky SD
    J Drugs Dermatol; 2011 Dec; 10(12):1413-20. PubMed ID: 22134565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mast cells in systemic and cutaneous lupus erythematosus.
    Kaczmarczyk-Sekuła K; Dyduch G; Kostański M; Wielowieyska-Szybińska D; Szpor J; Białas M; Okoń K
    Pol J Pathol; 2015 Dec; 66(4):397-402. PubMed ID: 27003772
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus.
    Sontheimer RD; Maddison PJ; Reichlin M; Jordon RE; Stastny P; Gilliam JN
    Ann Intern Med; 1982 Nov; 97(5):664-71. PubMed ID: 6982644
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunohistological studies, with anti-connective tissue and anti-immunoglobulin antisera, of the skin in lupus erythematosus and scleroderma.
    Rowell NR; Scott DG
    Br J Dermatol; 1975 Oct; 93(4):431-41. PubMed ID: 1081402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.
    Ruuska P; Hämeenkorpi R; Forsberg S; Julkunen H; Mäkitalo R; Ilonen J; Tiilikainen A
    Ann Rheum Dis; 1992 Jan; 51(1):52-5. PubMed ID: 1540038
    [TBL] [Abstract][Full Text] [Related]  

  • 79. T helper 17 cell population in lupus erythematosus.
    Bălănescu P; Bălănescu E; Tănăsescu C; Nicolau A; Tănăsescu R; Grancea C; Vagu C; Ruţă S; Bleoţu C
    Rom J Intern Med; 2010; 48(3):255-9. PubMed ID: 21528751
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distinguishing subacute cutaneous from other types of lupus erythematosus.
    McCauliffe DP
    Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.